Stocks and InvestingStocks and Investing
Fri, March 8, 2024
Thu, March 7, 2024

Andreas Argyrides Maintained (AQST) at Buy with Increased Target to $9 on, Mar 7th, 2024


Published on 2024-10-28 09:32:11 - WOPRAI, Andreas Argyrides
  Print publication without navigation


Andreas Argyrides of Wedbush, Maintained "Aquestive Therapeutics, Inc." (AQST) at Buy with Increased Target from $4 to $9 on, Mar 7th, 2024.

Andreas has made no other calls on AQST in the last 4 months.



There is 1 other peer that has a rating on AQST. Out of the 1 peers that are also analyzing AQST, 0 agree with Andreas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andreas


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $6 on, Wednesday, November 8th, 2023